EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO SANDOZ 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO SANDOZ 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Pending
Register Number
82517
Prescription Type
Uso Hospitalario
Authorization Date
Oct 8, 2017
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number82517
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (3)
EFAVIRENZActive
Quantity: 600 mg
Name: EFAVIRENZ
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR DISOPROXILO SUCCINATOActive
Quantity: 300,6 mg
Name: TENOFOVIR DISOPROXILO SUCCINATO
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR06